Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 22:18:eAO5070.
doi: 10.31744/einstein_journal/2020AO5070. eCollection 2020.

Prevalence of priapism in individuals with sickle cell disease and implications on male sexual function

[Article in English, Portuguese]
Affiliations

Prevalence of priapism in individuals with sickle cell disease and implications on male sexual function

[Article in English, Portuguese]
Mateus Andrade Alvaia et al. Einstein (Sao Paulo). .

Abstract

Objective: To evaluate epidemiological aspects of priapism in patients with sickle cell disease, and these aspects impact on adult sexual function.

Methods: This was a cross-sectional study including individuals with sickle cell disease who were evaluated at a reference center for sickle cell. Participants completed a structured questionnaire about their sociodemographic characteristics and priapism events. Sexual function was assessed using validated two instruments, the Erection Hardness Score and one about the sex life satisfaction.

Results: Sixty-four individuals with median aged of 12 (7 to 28) years were interviewed. The prevalence of priapism was 35.9% (23/64). The earliest priapism episode occurred at 2 years of age and the latest at 42 years. The statistical projection was that 71.1% of individuals of the study would have at least one episode of priapism throughout life. Patients with episodes of priapism (10/23) had significantly worse erectile function Erection Hardness Score of 2 [1-3]; p=0.01 and were less satisfied with sexual life 3 [3-5]; p=0.02.

Conclusion: Priapism is usually present in childhood, and severe episodes are associated with cavernous damage, impairment in the quality of the erection, and lower sexual satisfaction.

Objetivo: Avaliar aspectos epidemiológicos do priapismo em pacientes com doença falciforme e o impacto desses aspectos na função sexual de adultos.

Métodos: Trata-se de estudo transversal, que incluiu indivíduos com doença falciforme acompanhados em um centro de referência. Os participantes responderam a um questionário estruturado acerca das características sociodemográficas e eventos de priapismo. A função sexual foi avaliada por meio de dois instrumentos validados, a Escala de Rigidez de Ereção e um sobre satisfação com a vida sexual.

Resultados: Foram entrevistados 64 indivíduos com média de idade de 12 (7-28) anos. A prevalência de priapismo foi de 35,9% (23/64). O episódio mais precoce ocorreu aos 2 anos de idade e o mais tardio, aos 42 anos. A projeção estatística foi de que 71,1% desses sujeitos teriam pelo menos um episódio de priapismo ao longo da vida. Pacientes adultos com episódios de priapismo (10/23) apresentaram função erétil significativamente pior Escala de Rigidez de Ereção de 2 [1-3]; p=0,01 e estavam menos satisfeitos com a vida sexual 3 [3-5]; p=0,02.

Conclusão: O priapismo manifesta-se desde a infância, e episódios graves estão associados a dano cavernoso, prejuízo na qualidade da ereção e menor satisfação sexual.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: none.

Figures

Figure 1
Figure 1. Tool for Erection Hardness Score assessment
Figure 2
Figure 2. Estimation of complication-free interval regarding priapism and prolonged erection in patients with sickle cell disease
Figure 3
Figure 3. Erection Hardness Scores in patients with sickle cell disease, priapism and prolonged erection
Figure 4
Figure 4. Satisfaction with sex life in the patients with sickle cell disease and priapism or prolonged erection
Figura 1
Figura 1. Ferramenta para avaliação da Escala de Rigidez de Ereção
Figura 2
Figura 2. Estimativa de intervalo livre de complicação em relação ao priapismo e à ereção prolongada em pacientes com doença falciforme
Figura 3
Figura 3. Escala de Rigidez de Ereção em pacientes com doença falciforme, priapismo e ereção prolongada
Figura 4
Figura 4. Satisfação com vida sexual em pacientes com doença falciforme, priapismo ou ereção prolongada

References

    1. 1. Reis FM, Branco RR, Conceição AM, Trajano AM, Vieira JF, Ferreira PR, et al. Incidence of variant hemoglobins in newborns attended by a public health laboratory. einstein (São Paulo). 2018;16(2):eAO4150. - PMC - PubMed
    2. Reis FM, Branco RR, Conceição AM, Trajano AM, Vieira JF, Ferreira PR, et al. einstein. 2. Vol. 16. São Paulo: 2018. Incidence of variant hemoglobins in newborns attended by a public health laboratory; eAO4150. - PMC - PubMed
    1. 2. Felix AA, Souza HM, Ribeiro SB. Aspectos epidemiológicos e sociais da doença falciforme. Rev Bras Hematol Hemoter. 2010;32(3):203-8.
    2. Felix AA, Souza HM, Ribeiro SB. Aspectos epidemiológicos e sociais da doença falciforme. Rev Bras Hematol Hemoter. 2010;32(3):203–208.
    1. 3. Ugwumba F, Ekwedigwe HC, Echetabu KN, Okoh AS, Nnabugwu I, Ugwuidu ES. Ischemic priapism in South-East Nigeria: presentation, management challenges, and aftermath issues. Niger J Clin Pract. 2016;19(2):207-11. - PubMed
    2. Ugwumba F, Ekwedigwe HC, Echetabu KN, Okoh AS, Nnabugwu I, Ugwuidu ES. Ischemic priapism in South-East Nigeria: presentation, management challenges, and aftermath issues. Niger J Clin Pract. 2016;19(2):207–211. - PubMed
    1. 4. Arduini GA, Rodrigues LP, Trovó de Marqui AB. Mortality by sickle cell disease in Brazil. Rev Bras Hematol Hemoter. 2017;39(1):52-6. - PMC - PubMed
    2. Arduini GA, Rodrigues LP, Trovó de Marqui AB. Mortality by sickle cell disease in Brazil. Rev Bras Hematol Hemoter. 2017;39(1):52–56. - PMC - PubMed
    1. 5. Burnett AL, Anele UA, Trueheart IN, Strouse JJ, Casella JF. Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease. Am J Med. 2014;127(7):664-8. - PMC - PubMed
    2. Burnett AL, Anele UA, Trueheart IN, Strouse JJ, Casella JF. Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease. Am J Med. 2014;127(7):664–668. - PMC - PubMed

MeSH terms